SCHEMBL7704922

SCHEMBL7704922

CCC(c1ccc2c(c1)NC(=O)C(C)O2)N(Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.48
HSD17B10 Q99714 3/20 0.41
ALOX15 P16050 2/20 0.41
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMYD3 Q9H7B4 3/20 0.35
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
NCOR2 Q9Y618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7088859 0.91 PARP1 (0.37) PARP1HSD17B10ALOX15MAPK1ALDH1A1
SCHEMBL7711223 0.87 PARP1 (0.38) PARP1HSD17B10ALDH1A1HTTSMYD3
SCHEMBL7710846 0.83 PARP1 (0.53) PARP1HSD17B10ALOX15MAPK1ALDH1A1
SCHEMBL7711130 0.83 PARP1 (0.53) PARP1HSD17B10ALOX15MAPK1ALDH1A1
SCHEMBL7710216 0.81 HSD17B10 (0.35) HSD17B10ALOX15ALDH1A1L3MBTL1HDAC3
SCHEMBL7713376 0.81 PARP1 (0.56) PARP1HSD17B10ALOX15MAPK1ALDH1A1
SCHEMBL5188614 0.80 PARP1 (0.46) PARP1HSD17B10ALOX15MAPK1ALDH1A1
SCHEMBL7710218 0.80 HTR2C (0.33) HSD17B10ALDH1A1L3MBTL1HDAC3HDAC1
SCHEMBL6305893 0.79 PARP1 (0.54) PARP1HSD17B10ALOX15MAPK1ALDH1A1
SCHEMBL7089254 0.79 HTT (0.35) HSD17B10ALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed